We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+30.44%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$270M
AUM Growth
+$53.8M
Cap. Flow
+$13.5M
Cap. Flow %
4.99%
Top 10 Hldgs %
73.27%
Holding
33
New
7
Increased
5
Reduced
7
Closed
4

Top Buys

1
KURA icon
Kura Oncology
KURA
+$19.3M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$19.1M
3
CYTK icon
Cytokinetics
CYTK
+$13.9M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$9.48M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$8.55M

Top Sells

1
ATRA icon
Atara Biotherapeutics
ATRA
+$25.3M
2
EPZM
Epizyme, Inc
EPZM
+$11.8M
3
KITE
Kite Pharma, Inc.
KITE
+$8.12M
4
CASC
Cascadian Therapeutics, Inc.
CASC
+$2.58M
5
OREX
Orexigen Therapeutics, Inc.
OREX
+$1.98M

Sector Composition

1 Healthcare 84.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
1
Kyntra Bio
KYNB
$29.8M
$37.1M 13.73%
48,659
-557
-1% -$370K
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$29.8M 11.05%
719,000
+570,000
+383% +$19.1M
TVTX icon
3
Travere Therapeutics
TVTX
$5.27B
$23.6M 8.75%
1,224,384
+216,724
+22% +$4.33M
KURA icon
4
Kura Oncology
KURA
$1.01B
$20.6M 7.62%
+2,450,000
New +$19.3M
ASMB icon
5
Assembly Biosciences
ASMB
$530M
$15.8M 5.84%
174,859
+17,603
+11% +$1.92M
CYTK icon
6
Cytokinetics
CYTK
$11.2B
$14.8M 5.5%
+1,418,700
New +$13.9M
COLL icon
7
Collegium Pharmaceutical
COLL
$1.19B
$12.8M 4.74%
465,118
– –
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$11.2M 4.15%
698,900
-793,800
-53% -$11.8M
LKFT
9
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
$10.5M 3.9%
+167,361
New +$8.55M
KITE
10
DELISTED
Kite Pharma, Inc.
KITE
$10.2M 3.79%
166,000
-115,400
-41% -$8.12M
DCOY
11
Decoy Therapeutics
DCOY
$3.26M
$9.9M 3.67%
1
– –
IRWD icon
12
Ironwood Pharmaceuticals
IRWD
$658M
$9.52M 3.53%
+980,908
New +$9.48M
NBRV
13
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$7.93M 2.94%
3,355
+13
+0.4% +$31.7K
ATYR
14
aTyr Pharma
ATYR
$52.4M
$7.77M 2.88%
56,462
-3,571
-6% -$508K
KIN
15
DELISTED
Kindred Biosciences, Inc.
KIN
$4.87M 1.8%
1,432,765
+109,334
+8% +$507K
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.18M 1.55%
6,318
– –
TPST icon
17
Tempest Therapeutics
TPST
$16.8M
$4.15M 1.54%
+145
New +$4.78M
GNVC
18
DELISTED
GenVec, Inc.
GNVC
$3.53M 1.31%
192,091
-6,550
-3% -$125K
CALA
19
DELISTED
Calithera Biosciences, Inc
CALA
$3.18M 1.18%
20,774
– –
LRMR icon
20
Larimar Therapeutics
LRMR
$396M
$2.32M 0.86%
+30,750
New +$4.94M
FWP
21
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$1.9M 0.7%
14,288
-283
-2% -$45.4K
AKTX
22
Akari Therapeutics
AKTX
$21.2M
$1.46M 0.54%
126
– –
NRX
23
DELISTED
NEPHROGENEX INC COM
NRX
$941K 0.35%
+588,235
New +$1.37M
QLTI
24
DELISTED
QLT Inc
QLTI
$266K 0.1%
100,000
-538,900
-84% -$1.52M
ATRA icon
25
Atara Biotherapeutics
ATRA
$76.8M
– –
-32,138
Closed -$25.3M
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return